High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.4M
$1,426,817
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PCRX |
Pacira BioSciences, Inc.
|
Director
Discretionary Sell
|
2026-03-17 | $10,905 | S | Form 4 |
|
PCRX
S
Pacira BioSciences, Inc.
SLONIN JONATHAN
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-17
$74,416
|
||||||
| PCRX |
Pacira BioSciences, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-17 | $74,416 | S | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
President
10b5-1 Sell
|
2026-02-02 | $83,240 | S | Form 4 |
|
PCRX
S
Pacira BioSciences, Inc.
WILLIAMS KRISTEN
• Officer • Chief Administrative Officer
10b5-1 Sell
2026-02-02
$269,703
|
||||||
| PCRX |
Pacira BioSciences, Inc.
|
Officer • Chief Administrative Officer
10b5-1 Sell
|
2026-02-02 | $269,703 | S | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
CFO
Equity Compensation
|
2025-12-10 | $149,761x2 | M | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
CFO
10b5-1 SellΔOwn -13.9%
|
2025-12-10 | $228,875 | S | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
CFO
Equity Compensation
|
2025-12-09 | $261,489x2 | M | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
CFO
10b5-1 SellΔOwn -22.0%
|
2025-12-09 | $397,877 | S | Form 4 |
|
PCRX
S
Pacira BioSciences, Inc.
SLONIN JONATHAN
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-17
$95,396
|
||||||
| PCRX |
Pacira BioSciences, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-17 | $95,396 | S | Form 4 |
| PCRX |
Pacira BioSciences, Inc.
|
CFO
10b5-1 SellΔOwn -17.6%
|
2025-11-10 | $266,405 | S | Form 4 |